Notify me when Jonathan M. Cohen files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| 20/20 Biolabs, Inc. | Common Stock, par value $0.01 | 17% | 1,833,750 | Jonathan M Cohen | 03 Mar 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|